Skip Ribbon Commands
Skip to main content

UCHealth Home

:

Clinical Trials: RTOG 0538 Phase III comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide

 


RTOG 0538 Phase III comparison of thoracic radiotherapy regimens in patients with limited small cell lung cancer also receiving cisplatin and etoposide


Trial Focus

Lung Cancer

Objective

         Clinical trial of high dose radiation which consists of either receiving radiation once a day with high total dose of radiation for 7 weeks and is investigational, or receiving radiation once a day for 16 days of treatment (about 3 weeks), followed by twi

IRB Protocol #

08-0397

Trial Status

OPEN

Principle Investigator

LAURIE GASPAR

Sponsor

RTOG

Contact

ROBYN SWING at (720)848-0607 or ROBYN.SWING@UCDENVER.EDU

Location

National Jewish Hospital University of Colorado Hospital National Jewish Hospital University of Colorado Hospital

Eligibility and Other Participant Information


What To Expect : A screening period to determine eligibility. A treatment period (s) that can last up to twelve weeks. A follow up period will consist of clinic visits every 3 months for 2 years, every 6 months for 3 years, and then at least every year for 5 years. // Eligibility criteria include but are not limited to 18 years or older with lung cancer.Eligibility criteria include but are not limited to 18 years or older with lung cancer.